Biological E. Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 4.95 Cr
- Company Age 71 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2,819.72 Cr
- Satisfied Charges ₹ 2,659.04 Cr
- Revenue Growth 45.68%
- Profit Growth 130.09%
- Ebitda 80.07%
- Net Worth 41.66%
- Total Assets 8.96%
About Biological E.
Biological E. Limited (BEL) was founded in India on 10 December 1953 and has a glorious history of 71 years and one month. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Evans Medical Supplies (India) Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.95 Cr.
The company currently has active open charges totaling ₹2,819.72 Cr. The company has closed loans amounting to ₹2,659.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Biological E. Limited India is Saddi Reddy as COMPANY SECRETARY. Ippagunta Rao, Indira Rajupusapati, Mantena Purnima, and Two other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U01120TG1953PLC001095
- Company No.
001095
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Dec 1953
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Biological E. Limited offer?
Biological E. Limited offers a wide range of products and services, including Switches & Switch Boxes, Modular Switches, GM Modular Switches, Anti Infective Drugs & Medicines, Antibacterial Drugs, Digestive System Drugs & Medicines, Gastrointestinal Drugs.
Who are the key members and board of directors at Biological E.?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saddi Reddy  | Company Secretary | Current | |
| Mahima Datla | Managing Director | 10-Apr-2013 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ippagunta Rao | Director | 23-May-2017 | Current |
| Indira Rajupusapati | Whole-Time Director | Current | |
| Mantena Purnima | Whole-Time Director | Current | |
| Rudaraju Kumar | Whole-Time Director | 16-Oct-2017 | Current |
Financial Performance of Biological E..
Biological E. Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 45.68% increase. The company also saw a substantial improvement in profitability, with a 130.09% increase in profit. The company's net worth Soared by an impressive increase of 41.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biological E.?
In 2023, Biological E. had a promoter holding of 99.94% and a public holding of 0.05%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
V.R.Construction Pvt LtdIndira Rajupusapati and Mantena Purnima are mutual person
Dr.Reddy's Institute Of Life SciencesMahima Datla is a mutual person
Vaxenic India Private LimitedIndira Rajupusapati, Mantena Purnima and 2 more are mutual person
Be Pharmaceuticals Private LimitedMahima Datla and Rudaraju Kumar are mutual person
Orient Cement LimitedIppagunta Rao is a mutual person
Clini-Pharma LlpIndira Rajupusapati and Mahima Datla are mutual person
Charges (Loans)
₹2,819.72 Cr
₹2,659.04 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 813.34 Cr
- Sbicap Trustee Company Limited : 657.00 Cr
- Hdfc Bank Limited : 580.00 Cr
- Axis Bank Limited : 467.14 Cr
- Others : 300.00 Cr
- Others : 2.24 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Dec 2023 | Axis Bank Limited | ₹2.14 Cr | Open |
| 17 Nov 2022 | Others | ₹300.00 Cr | Open |
| 31 May 2022 | Hdfc Bank Limited | ₹350.00 Cr | Open |
| 12 Apr 2022 | State Bank Of India | ₹813.34 Cr | Open |
| 22 Mar 2022 | Axis Bank Limited | ₹100.00 Cr | Open |
How Many Employees Work at Biological E.?
Biological E. has a workforce of 0 employees as of Sep 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biological E., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biological E.'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
